523,908 Shares in Option Care Health, Inc. $OPCH Purchased by Jupiter Asset Management Ltd.

Jupiter Asset Management Ltd. purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 523,908 shares of the company’s stock, valued at approximately $14,544,000.

A number of other large investors have also added to or reduced their stakes in the company. Cornerstone Planning Group LLC boosted its position in shares of Option Care Health by 7,621.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after acquiring an additional 1,067 shares during the last quarter. McIlrath & Eck LLC purchased a new stake in Option Care Health during the second quarter valued at $37,000. Hantz Financial Services Inc. lifted its position in Option Care Health by 987.7% during the third quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock valued at $39,000 after purchasing an additional 1,284 shares during the last quarter. Elevation Point Wealth Partners LLC bought a new position in Option Care Health during the second quarter valued at $40,000. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after buying an additional 1,183 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Up 0.1%

Shares of NASDAQ:OPCH opened at $35.69 on Friday. Option Care Health, Inc. has a 1 year low of $24.24 and a 1 year high of $36.80. The business has a 50 day simple moving average of $33.92 and a two-hundred day simple moving average of $30.38. The firm has a market capitalization of $5.67 billion, a PE ratio of 28.33, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft upped their target price on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Stephens raised Option Care Health to a “strong-buy” rating in a research note on Thursday, December 11th. Barrington Research raised their price objective on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Bank of America lifted their target price on Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. Finally, Citigroup restated an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $37.58.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.